Seal of Good Local Governance (SGLG) 2024Final.pptx
Template Review Meeting NVHCP.............-1.pptx
1. NATIONAL VIRAL HEPATITIS CONTROL PROGRAM
(NVHCP), C.G.
District name -……………………
District Nodal Officer NVHCP-……………………...................
2. District Testing Center
S. No Indicator Remark
1
Name of Nodal Officer for Testing Center -……………………………………………………….
Contact No.- ………………..
2
Viral Load Testing Facility (Yes/ No, if Yes Mention type TrueNat
or RTPCR )
3
-Viral Load Kit Availability (Yes/ No)
-RD kit Availability (Yes/ No if Yes then mention type Whole
blood/ Serum based)
4 Person responsible for Entry in MIS Portal (DEO/Lab Technician)
5 Training given to LT & DEO (Yes/No)
6 Screening facility available upto DH/CHC/PHC/ HWC other ..
3. District Treatment Center
S. No Indicator Remark
1
Name of Nodal Officer for Treatment Center -……………………
Contact No.- ………………..
2 Entry in Treatment Card done by Staff nurse / Pharmacist
3
Drug Distribution System-
From Treatment Center or Central distribution
4
Person responsible for entry in NVHCP MIS Portal-
Pharmacist or DEO or Other
5 Peer Supporter Recruitment (Yes/ No)
4. Training & Capacity Building
S. No Manpower (Training) Remark (Yes/No)
1
Medical Officer (Treatment) appointed in District Treatment
Center
2 Data Entry Operator
3 Lab Technician/MLT
4 Pharmacist
5 Staff Nurse
5. Maternal Health-ANC
S. No Indicator Remark(April To February)
1
ANC Screening up to which facility center
2 Number of ANC Screened for Hepatitis B
3 Number of pregnant women who are HBsAg positive
4
Number of pregnant women found positive for HBsAg
delivered in institution
5
Number of newborn to pregnant women (found positive for
HBsAg) received HBIG
6 Process of Referral of Positive pregnant women
6. Interdepartmental Coordination
• National Aids Control Program(NACO)
High Risk Group Hepatitis B Screening facility in ICTC or ART-
Positive Patients Referral System-
Hep B Immunization of negative HRG-
Responsibility of Positive Patients Portal entry –
• Child Health
Number of New Born Zero Dose (April To February) -
HBIG Availability up to which level(also mention quantity)-
7. • Blood Bank (April To February)
Number of donors screened for Hep B-
Number of donors screened for Hep C-
Positive Patients Referral System-
Responsibility of Positive Patients Portal entry –
Interdepartmental Coordination
Last DVHMU Meeting conducted – ……/....../……
8. Vaccination of Health Care Worker
S.
No
Facility level (April To
February)
Number of HCW
Vaccinated
Pending/Reason
1 District Hospital
2 Community Health Center
3 Primary Health Center
4 Sub Center
5 Health & Wellness Center
6 Community Level
9. High Risk Group Camp
S.
No
HRG Type
(April To
February)
Number of Person Hep B
Screened
Number of Person Hep C
Screened
Vaccination
Status
1 Prisoner
2
HIV Positive
Patients
3 Migrants
4 Truckers
5
Intravenous Drug
Users
6 Others
10. Hepatitis B & C Drug status
HEPATITIS - B DRUGS
ENTACAVIR 0.5MG ENTACAVIR 1MG TENOFOVIR 300MG RIBAVIRIN 200MG
STOCK
AVAILABLE
EXPIRY DETAILS
STOCK
AVAILABLE
EXPIRY DETAILS
STOCK
AVAILABLE
EXPIRY DETAILS
STOCK
AVAILABLE
EXPIRY DETAILS
……….
HEPATITIS - C DRUGS
DECLATASVIR 60MG SOFOSBUVIR 400MG SOFOSBUVIR 400MG+VELPATASVIR 100MG
STOCK AVAILABLE EXPIRY DETAILS STOCK AVAILABLE EXPIRY DETAILS STOCK AVAILABLE EXPIRY DETAILS
Note**- Stock total in number of tablets.